Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.882 USD | -0.64% | +2.54% | +15.26% |
04-25 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.26% | 38.76M | |
+7.33% | 111B | |
+11.30% | 106B | |
-12.45% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.94% | 16.81B | |
+37.66% | 12.54B | |
-24.33% | 8.09B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Says VitaGraft Kidney Diagnostic Test to Receive Medicare, Medicaid Coverage